Zeev's Turnips Patch-No Politics (ZEEV)

[jim heger]

tuna, i see you once traded UGNE (Unigene $4.00). Have you followed the latest news - Merck's 2nd biggest selling drug
Fosamax ($3B in sales) is under attack with claims of causing
jaw bone degeneration. From WSJ :
"Fosamax Drug
Could Become
Next Merck Woe
By JOHN CARREYROU
April 12, 2006; Page B1

As Merck & Co. was hit with big punitive damages in a Vioxx case yesterday, plaintiffs' attorneys are setting their sights on one of the company's other blockbusters: osteoporosis drug Fosamax.

The drug maker is facing 10,000 lawsuits related to its painkiller Vioxx, which it pulled from the market in 2004 after a study showed that using the drug for 18 months or longer increased the risk of heart attacks and strokes. Now, adding to Merck's woes are reports that link long-term use of Fosamax to a rare disease in which a patient's jawbone rots and dies, called osteonecrosis of the jaw, or ONJ.
______________

With its Fortical, a leading alternative to Fosamax, it seems to me that UGNE stands to reap windfall sales. what you think?